Metsera shareholders vote for $10 billion acquisition by Pfizer
Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner.
Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle
Novo Nordisk shares rise after dropping Metsera bid
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Novo CEO says its bid for Metsera is higher
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
Pfizer preparing to raise its bid for Metsera, WSJ reports
Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk
Delaware judge says she will not block Metsera from ending Pfizer deal
Pfizer says it removed some conditions from its Metsera bid
Healthy Returns: What to know about Pfizer and Novo Nordisk's bidding war over obesity biotech Metsera
Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera
Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo
Metsera said it received a revised acquisition offer from Novo Nordisk that it called superior to Pfizer's bid
Metsera says Novo Nordisk's new bid for obesity drugmaker is ‘superior' to revised Pfizer offer
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Novo Nordisk says Metsera bid won't raise antitrust issues
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech